Recuro Health has closed a $47 million Series B financing round


Recuro Health, an integrated digital health solutions company aimed at transitioning the United States’ healthcare system from a reactive, disease-focused model to a proactive care approach, has announced the completion of a $47 million Series B round of funding. ARCH Venture Partners, the Flippen Group, GPG Ventures, 4D Capital, and other investors are among the Series B syndicate’s new and existing investors.

Recuro plans to use the proceeds to advance and scale its Digital Medical Home, which includes diagnostic-enabled Virtual Primary Care and Virtual Behavioral Health Solutions tailored to any population’s healthcare needs.

To better inform integrated care, the Digital Medical Home care model integrates advanced science, data, at-home diagnostics, and targeted genomics — cancer screening, pharmacogenomics.

Recuro’s digital health solutions are currently available throughout the country and are used by millions of members.Recuro is proving to be the best of breed in the intersection of science, diagnostics, and digital health, says Robert Nelsen, co-founder and managing director of ARCH Venture Partners.

This agile organization is able to respond quickly to market changes, scale its tech-enabled services, and close care gaps that improve population health. We see numerous opportunities for exceptional growth and long-term success.

Recuro, which was founded in 2021, has earned industry recognition as a pioneer in developing innovative digital solutions that integrate Virtual Primary Care and Urgent Care, Behavioral Health, at-home lab testing, genomics, and a suite of enabling capabilities such as care navigation, data analytics, quality, and guided referrals.

Recuro is a provider of integrated digital health solutions with a distinctively personalized, proactive approach to virtual health.

Recuro’s Digital Medical Home provides simple access to virtual care, including primary and urgent care, behavioral health, at-home lab testing, genomics testing, and a suite of supplemental benefits spanning pharmacy, care management, and care navigation, all on a single platform.

Related Stories